Cm. Rao et al., SPECIFICITY IN THE BINDING OF INHIBITORS TO THE ACTIVE-SITE OF HUMAN PRIMATE ASPARTIC PROTEINASES - ANALYSIS OF P2-P1-P1'-P2' VARIATION, Journal of medicinal chemistry, 36(18), 1993, pp. 2614-2620
To understand the differences in the binding specificities within the
aspartic proteinase family of enzymes, we have carried out studies to
determine the inhibition constants of a set of related compounds with
various members of the human enzyme family. The inhibition constants (
K(i) values) were determined by competitive inhibition of the hydrolys
is of chromogenic octapeptide substrates in the pH range of 3-5. For c
omparison, inhibition of monkey renin was studied by RIA at pH 6.0. Al
l inhibitors were based on the general structure yl)-L-Phe-P2-(cyclohe
xyl)Alapsi[isostere]-P1'-P2'. The isosteric replacements of the scissi
le peptide bond included difluorohydroxyethylene, 1,2-diols, 1,3-diols
, and difluoroketones. Side chain substituents in P2 include hydrogen,
allyl, ethylthio, (methoxycarbonyl)methyl, N-methylthiouridobutyl, im
idazolylmethyl, and 4-amino-2-thiazolylmethyl. Our measurements have i
dentified potent and selective inhibitors which are useful in evaluati
ng the differences in the specificities among selected enzymes of this
family.